Matches in Wikidata for { <http://www.wikidata.org/entity/Q57823674> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q57823674 description "article scientifique publié en 2018" @default.
- Q57823674 description "artículu científicu espublizáu n'agostu de 2018" @default.
- Q57823674 description "im August 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q57823674 description "scientific article published on 01 August 2018" @default.
- Q57823674 description "wetenschappelijk artikel" @default.
- Q57823674 description "наукова стаття, опублікована в серпні 2018" @default.
- Q57823674 name "Letter by Koh Regarding Article, "Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease"" @default.
- Q57823674 name "Letter by Koh Regarding Article, "Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease"" @default.
- Q57823674 type Item @default.
- Q57823674 label "Letter by Koh Regarding Article, "Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease"" @default.
- Q57823674 label "Letter by Koh Regarding Article, "Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease"" @default.
- Q57823674 prefLabel "Letter by Koh Regarding Article, "Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease"" @default.
- Q57823674 prefLabel "Letter by Koh Regarding Article, "Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease"" @default.
- Q57823674 P1433 Q57823674-F9AEA87B-3250-41A5-9FD8-8B2D2AFB20C6 @default.
- Q57823674 P1476 Q57823674-41033E38-1077-4881-B9B6-A5F945C77D98 @default.
- Q57823674 P2093 Q57823674-8FEA3483-2B69-4B51-A6B3-D663CDA6B9A5 @default.
- Q57823674 P304 Q57823674-55EFD648-E6E6-4964-8DED-A6CDBE5E2D51 @default.
- Q57823674 P31 Q57823674-B0D720D3-CD05-4F0C-A3BF-AADC05F93D53 @default.
- Q57823674 P356 Q57823674-296FD833-5A28-4AC5-80F8-D5BDEB25321E @default.
- Q57823674 P407 Q57823674-A9485C3E-EA1E-4791-9132-476BE3CB608B @default.
- Q57823674 P433 Q57823674-50806FF7-67B3-4ED6-BD48-ED4E6D1A7425 @default.
- Q57823674 P478 Q57823674-4EF48497-A20A-4C2F-BA53-E6B3722C6E5B @default.
- Q57823674 P577 Q57823674-C4B6E017-0062-4035-B776-B19CBF48E564 @default.
- Q57823674 P698 Q57823674-E74E1EFF-A5B6-4BE0-B260-D760A31C1DFC @default.
- Q57823674 P921 Q57823674-CAE6E14F-ABC0-464C-8DED-289C3B83063A @default.
- Q57823674 P921 Q57823674-F83A0F9C-1250-4762-9400-48897804DBAA @default.
- Q57823674 P921 Q57823674-FB903EE3-1BAF-4DF8-82CE-D745CF5F8BE3 @default.
- Q57823674 P356 CIRCULATIONAHA.118.033867 @default.
- Q57823674 P698 30359121 @default.
- Q57823674 P1433 Q578091 @default.
- Q57823674 P1476 "Letter by Koh Regarding Article, "Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease"" @default.
- Q57823674 P2093 "Kwang Kon Koh" @default.
- Q57823674 P304 "846-847" @default.
- Q57823674 P31 Q13442814 @default.
- Q57823674 P356 "10.1161/CIRCULATIONAHA.118.033867" @default.
- Q57823674 P407 Q1860 @default.
- Q57823674 P433 "8" @default.
- Q57823674 P478 "138" @default.
- Q57823674 P577 "2018-08-01T00:00:00Z" @default.
- Q57823674 P698 "30359121" @default.
- Q57823674 P921 Q3025883 @default.
- Q57823674 P921 Q389735 @default.
- Q57823674 P921 Q5373824 @default.